Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEFOPAIN kinetics
2025-521926-13-00Phase 4Authorised
- Sponsor
- Rouen University Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nefopam in acute musculoskeletal pain, sponsored by Rouen University Hospital. Primary endpoint: Pharmacokinetic parameters and bioavailability of oral versus intravenous nefopam. Planned start Sep 2026; status: authorised.
02
Drugs
nefopam
03
Conditions
acute musculoskeletal pain
Beyond the preview
Go deeper on 2025-521926-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521926-13-00.